Race and “omic” data in glioma: A systematic review of contemporary research to explore the digital divide
Open Access
- 31 January 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 12 (4) , 585-599
Abstract
Background: The expanding repertoire of studies generating genome-scale omic datasets from glioma samples provides a generational opportunity to uncover mechanisms driving aggressive biology and develop new treatments. However, ensuring such studies reflect the breadth of racial groups and ethnicities affected by gliomas is critical to support equity in future therapeutic advances. We therefore report a contemporary snapshot of the representation of race and ethnicity in omic glioma studies. Methods: We searched PubMed, Embase, Web of Science, and Scopus and systematically reviewed articles published between January and November 2023 reporting de novo genome-scale sequencing data generated using samples from patients diagnosed with glioma (according to World Health Organization 2021 criteria) to characterize the reporting and composition of race and ethnicity data. Results: Thirty-five studies involving 5601 patients were analyzed. Race or ethnicity data was reported in only 3 studies (8.6%), of which none provided omic data in a format that could be stratified by race or ethnicity. Reporting varied by continent with all 3 studies including race or ethnicity data based in North America. Where racial data was available, we found that samples used for genome-scale characterization came from patients reported as being White in 91.1% cases (41 patients), with 6.7% (3 patients) reported as Black and 2.2% (1 patient) as Hispanic. Conclusions: These studies underscore an urgent need for improved reporting and representation to enhance our understanding of glioma biology across different populations and guide targeted initiatives from policymakers and funders to support equitable improvements in healthcare.Keywords
Funding Information
- The Brain Tumour Charity (FL_2021_/1_10610)
- Wellcome Trust 4Ward North Clinical PhD Fellowship (R127002)
This publication has 68 references indexed in Scilit:
- Ethnicity in neuro-oncology research: How are we doing and how can we do better?Journal of Neuro-Oncology, 2024
- A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplificationCancer Medicine, 2023
- Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assayJournal of Neuro-Oncology, 2023
- RNA Sequencing of Intraoperative Peritumoral Tissues Reveals Potential Pathways Involved in Glioma-Related SeizuresJournal of Molecular Neuroscience, 2023
- Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastomaInternational Journal of Cancer, 2023
- Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumorsJournal of Neuro-Oncology, 2023
- Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarkerJournal of Neuro-Oncology, 2022
- Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastomaCancer Medicine, 2022
- Glioma risk associated with extent of estimated European genetic ancestry in African Americans and HispanicsInternational Journal of Cancer, 2019
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014JAMA Oncology, 2018